Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 10;15(4):942.
doi: 10.3390/v15040942.

Impact of Borna Disease Virus Infection on the Transcriptome of Differentiated Neuronal Cells and Its Modulation by Antiviral Treatment

Affiliations

Impact of Borna Disease Virus Infection on the Transcriptome of Differentiated Neuronal Cells and Its Modulation by Antiviral Treatment

Da Teng et al. Viruses. .

Abstract

Borna disease virus (BoDV-1) is a highly neurotropic RNA virus that causes neurobehavioral disturbances such as abnormal social activities and memory impairment. Although impairments in the neural circuits caused by BoDV-1 infection induce these disturbances, the molecular basis remains unclear. Furthermore, it is unknown whether anti-BoDV-1 treatments can attenuate BoDV-1-mediated transcriptomic changes in neuronal cells. In this study, we investigated the effects of BoDV-1 infection on neuronal differentiation and the transcriptome of differentiated neuronal cells using persistently BoDV-1-infected cells. Although BoDV-1 infection did not have a detectable effect on intracellular neuronal differentiation processes, differentiated neuronal cells exhibited transcriptomic changes in differentiation-related genes. Some of these transcriptomic changes, such as the decrease in the expression of apoptosis-related genes, were recovered by anti-BoDV-1 treatment, while alterations in the expression of other genes remained after treatment. We further demonstrated that a decrease in cell viability induced by differentiation processes in BoDV-1-infected cells can be relieved with anti-BoDV-1 treatment. This study provides fundamental information regarding transcriptomic changes after BoDV-1 infection and the treatment in neuronal cells.

Keywords: Borna disease virus; antiviral; differentiation; gene expression; neuronal cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Neuronal differentiation of BoDV-1-infected SH-SY5Y cells. (A) Differentiation protocol of SH-SY5Y cells used in this study. SH-SY5Y cells were differentiated with 10 µM retinoic acid (RA) for 2 days. (BD) Neuronal differentiation of BoDV-1-infected and uninfected SH-SY5Y cells. Neuronal differentiation was evaluated with the cell morphological changes (B), the total length of neurites in a cell (C), and the NCAM2 gene expression (D). (E) BoDV-1 infection in differentiated (RA) and undifferentiated (DMSO) SH-SY5Y/BoDV cells. Bars, 30 µm. We calculated the expression of each gene using the ∆∆Ct method. The expression of each gene was normalized with that of the GAPDH gene in each condition. Values are expressed as the mean percentage + standard error of the mean (SEM) of at least three independent experiments. N.S, non-significant; ***, p < 0.005; ****, p < 0.001.
Figure 2
Figure 2
Differentiation-related genes affected by BoDV-1 infection. (A,B) Scatter plots of RNA-seq analysis. Extracted genes are indicated in red. (A) Comparison between undifferentiated (X-axis) and differentiated (Y-axis) SH-SY5Y cells. (B) Comparison between differentiated SH-SY5Y/BoDV (X-axis) and differentiated SH-SY5Y cells (Y-axis). (C) Venn diagram showing the number of differentiation-related (left circle) and BoDV-1-impaired (right circle) genes identified by RNA-seq. The overlapped genes are indicated. (D) Heatmap showing the expression levels of BoDV-1-impaired, differentiation-related genes.
Figure 3
Figure 3
Suppression of BoDV-1 infection by TD-Borna treatment. (A) Effects of TD-Borna treatment on BoDV-1 load in SH-SY5Y/BoDV cells. SH-SY5Y/BoDV cells were treated with DMSO or RA in the presence or absence of TD-Borna for 2 days. The amounts of BoDV-1 gRNAs in SH-SY5Y/BoDV cells were determined by RT-qPCR analyses. (BD) The amounts of N (B), X/P (C), and M/G/L (D) mRNAs in SH-SY5Y/BoDV cells. The amounts of BoDV-1 mRNAs were determined by RT-qPCR analyses. (E) The amounts of BoDV-1 proteins in SH-SY5Y/BoDV cells. The amounts of BoDV-1 N, BoDV-1 P, and tubulin were determined by western blot analyses using specific antibodies. siCont, the scrambled siRNA-treated control; TD-Borna, the siRNA cocktail against BoDV-1. We calculated the expression of each gene using the ∆∆Ct method. The expression of each gene was normalized with that of the GAPDH gene in each condition. Values are expressed as the mean percentage + SEM of four independent experiments. ***, p < 0.005; ****, p < 0.001.
Figure 4
Figure 4
Effect of TD-Borna treatment on BoDV-1-related transcriptomic changes in differentiated SH-SY5Y cells. SH-SY5Y/BoDV cells were treated with RA in the presence of the scrambled siRNA (siCont) or TD-Borna for 2 days. The mRNA amounts of differentiation-related genes in the indicated cells were determined by RT-qPCR analyses. We calculated the expression of each gene using the ∆∆Ct method. The expression of each gene was normalized with that of the GAPDH gene in each condition. Values are expressed as the mean percentage + SEM of four independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001.
Figure 5
Figure 5
Effect of TD-Borna treatment on cell viability during differentiation of SH-SY5Y/BoDV cells. SH-SY5Y or SH-SY5Y/BoDV cells were treated with RA in the presence of the scrambled siRNA (siCont) or TD-Borna for 2 days. The cell viability was evaluated by using a CellTiter Glo Luminescent Cell Viability Assay. Values are expressed as the mean percentage + SEM of three independent experiments. ****, p < 0.001.

Similar articles

Cited by

References

    1. Amarasinghe G.K., Ayllón M.A., Bào Y., Basler C.F., Bavari S., Blasdell K.R., Briese T., Brown P.A., Bukreyev A., Balkema-Buschmann A., et al. Taxonomy of the order Mononegavirales: Update 2019. Arch. Virol. 2019;164:1967–1980. doi: 10.1007/s00705-019-04247-4. - DOI - PMC - PubMed
    1. Rubbenstroth D., Briese T., Dürrwald R., Horie M., Hyndman T.H., Kuhn J.H., Nowotny N., Payne S., Stenglein M.D., Tomonaga K., et al. ICTV Virus Taxonomy Profile: Bornaviridae. J. Gen. Virol. 2021;102:001613. doi: 10.1099/jgv.0.001613. - DOI - PMC - PubMed
    1. Staeheli P., Sauder C., Hausmann J., Ehrensperger F., Schwemmle M. Epidemiology of Borna disease virus. J. Gen. Virol. 2000;81:2123–2135. doi: 10.1099/0022-1317-81-9-2123. - DOI - PubMed
    1. Tomonaga K., Kobayashi T., Ikuta K. Molecular and cellular biology of Borna disease virus infection. Microbes Infect. 2002;4:491–500. doi: 10.1016/S1286-4579(02)01564-2. - DOI - PubMed
    1. Honda T., Tomonaga K. Nucleocytoplasmic shuttling of viral proteins in borna disease virus infection. Viruses. 2013;5:1978–1990. doi: 10.3390/v5081978. - DOI - PMC - PubMed

Publication types

Substances